curiaglobal.com Open in urlscan Pro
141.193.213.20  Public Scan

Submitted URL: http://amriglobal.com/
Effective URL: https://curiaglobal.com/
Submission Tags: tranco_l324
Submission: On May 28 via api from DE — Scanned from DE

Form analysis 1 forms found in the DOM

GET https://curiaglobal.com

<form class="main-nav__global-search-form" action="https://curiaglobal.com" method="get" role="search" __bizdiag="115" __biza="WJ__"><button class="main-nav__global-search-submit" type="submit">
    <svg class="icon__magnifying-glass" width="28px" height="28px" viewBox="0 0 28 28" version="1.1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink">
      <title>Icon - Magnifying Glass</title>
      <g id="icon__magnifying-glass--enclosing-group" stroke="none" stroke-width="1" fill="none" fill-rule="evenodd">
        <g id="icon__magnifying-glass--search-icon-group" transform="translate(2.000000, 2.000000)" fill="#000000">
          <path
            d="M10.2644706,0 C4.59037174,0 0,4.59037174 0,10.2644706 C0,15.9385695 4.59037174,20.5289412 10.2644706,20.5289412 C12.4637914,20.5289412 14.5040451,19.8276123 16.1935016,18.6164191 L21.006939,23.4295909 C21.3256041,23.7485216 21.7720009,23.9394552 22.2183977,23.9394552 C22.6645289,23.9394552 23.1109257,23.7803881 23.4295909,23.4295909 L23.4614574,23.3977244 C24.1309198,22.728262 24.2265194,21.6126683 23.4614574,20.9750724 L18.6480201,16.1935016 C19.8276123,14.5040451 20.5605422,12.4640569 20.5605422,10.2644706 C20.5286756,4.59037174 15.9385693,0 10.2644705,0 M10.2644706,3.41077951 C14.0257818,3.41077951 17.1181617,6.47102734 17.1181617,10.2644706 C17.1181617,11.698995 16.6717649,13.0376542 15.8429699,14.2172465 L15.1735075,15.1735075 L14.2172465,15.8427044 C13.0376542,16.6714993 11.6987294,17.1178961 10.2644706,17.1178961 C6.50289385,17.1178961 3.41077951,14.0579139 3.41077951,10.2644706 C3.41077951,6.47102734 6.50289385,3.41077951 10.2644706,3.41077951">
          </path>
        </g>
      </g>
    </svg>
  </button><input class="main-nav__global-search-input" type="text" name="s"></form>

Text Content

 * Quick Quote
 * Curia Express
 * Government Contracting
 * News
 * Careers

Icon - Magnifying Glass
Curia - Logo - Full
 * About
 * Biologics
 * Research and Development
 * Manufacturing
 * Lab Testing
 * Insights

Contact

About Us icons/utility/right caret

Partnering with Us icons/utility/right caret

Our People icons/utility/right caret

Our Facilities icons/utility/right caret

Biologics Overview icons/utility/right caret
Discovery icons/utility/right caret

Beacon

Molecular Biology

Viral Vectors & Cell Engineering

Antibody Discovery & Engineering

Recombinant Antibody Production

Recombinant Protein Production

Development icons/utility/right caret

Stable CHO Cell Line

Upstream Process Development

Downstream Process Development

Formulation Development

Analytical Development

Antibody Developability Analysis

FAQ

Manufacturing icons/utility/right caret

Mammalian GMP Overview

Quality Systems

Process Development

Therapeutic GMP Manufacturing

Diagnostic GMP Manufacturing

Biorepository Service

Analytical Development

Assays & Bioanalytics icons/utility/right caret

Bioanalytical Assays

Biological and Functional Assays

 

Resources icons/utility/right caret

Sample Submission Forms

Client Secure Portal

Research & Development Overview icons/utility/right caret
Discovery icons/utility/right caret

Biology

Lead Optimization

Libraries

Synthetic & Medicinal Chemistry

Curia Express

Development icons/utility/right caret

Chemical Process R&D

Clinical Manufacturing

Fermentation

Formulation Development

High Potency

Kilo Lab & Small-Scale GMP API Manufacturing

Lipid Nanoparticle

Method Development / Material Science

Rare / Orphan

Separation Science

Consultative Services icons/utility/right caret

Intellectual Property Litigation Support

Intellectual Property Services

Regulatory Support

Quality Assurance

Sterile University

 
Manufacturing Overview icons/utility/right caret

Custom API Manufacturing

Fermentation

Finished Dosage Form

High Potency

Lipid Nanoparticle

Rare / Orphan

Stability & Release Testing

Sterile Fill Finish

APIs & Intermediates Catalog

Fine Chemicals Catalog

Consultative Services icons/utility/right caret

Intellectual Property Litigation Support

Intellectual Property Services

Regulatory Support

Quality Assurance

Sterile University

 
Lab Testing Services Overview icons/utility/right caret

Analytical Testing Services

Batch Release & Stability Lot Testing

Method Development & Validation

Package & Device Testing

Preformulation & Material Science

Solid State Chemistry



Curia - Logo - Full
Icon - Magnifying Glass


 * About us icons/utility/right caret
 * Biologics icons/utility/right caret
 * Research & Development icons/utility/right caret
 * Manufacturing icons/utility/right caret
 * Lab Testing icons/utility/right caret
 * Insights
 * Contact us

 * Quick Quote
 * Curia Express
 * Government Contracting
 * News

 * Careers
 * Suppliers

 * About Us
 * Partnering with Us
 * Our People
 * Our Facilities

 * Biologics Overview
 * Discovery icons/utility/right caret
 * Development icons/utility/right caret
 * Manufacturing icons/utility/right caret
 * Assays & Bioanalytics icons/utility/right caret
 * Resources icons/utility/right caret

 * Research & Development Overview
 * Discovery icons/utility/right caret
 * Development icons/utility/right caret
   
 * Consultative Services icons/utility/right caret

 * Manufacturing Overview
 * Custom API Manufacturing
 * Fermentation
 * Finished Dosage Form
 * High Potency
 * Lipid Nanoparticle
 * Rare / Orphan
 * Stability & Release Testing
 * Sterile Fill Finish
 * APIs & Intermediates Catalog
 * Fine Chemicals Catalog
   
   
 * Consultative Services icons/utility/right caret

 * Lab Testing Overview
 * Analytical Testing Services
 * Batch Release & Stability Lot Testing
   
 * Method Development & Validation
 * Package & Device Testing
 * Preformulation & Material Science
 * Solid State Chemistry

 * Discovery Overview
 * Biology
 * Lead Optimization
 * Libraries
 * Synthetic & Medicinal Chemistry
 * Curia Express

 * Development Overview
 * Chemical Process R&D
 * Clinical Manufacturing
 * Fermentation
 * Formulation Development
 * High Potency
 * Kilo Lab & Small-Scale GMP API Manufacturing
 * Lipid Nanoparticle
 * Method Development / Material Science
 * Rare / Orphan
 * Separation Science

 * Consultative Services Overview
 * Intellectual Property Litigation Support
 * Intellectual Property Services
   
 * Regulatory Support
 * Quality Assurance
 * Sterile University

 * Beacon
 * Molecular Biology
 * Viral Vectors & Cell Engineering
 * Antibody Discovery & Engineering
 * Recombinant Antibody Production
 * Recombinant Protein Production

 * Stable CHO Cell Line
 * Upstream Process Development
 * Downstream Process Development
 * Formulation Development
 * Analytical Development
 * Antibody Developability Analysis
 * FAQ

 * Mammalian GMP Overview
 * Quality Systems
 * Process Development
 * Therapeutic GMP Manufacturing
 * Diagnostic GMP Manufacturing
 * Biorepository Service
 * Analytical Development

 * Bioanalytical Assays
 * Biological and Functional Assays

 * Sample Submission Forms
 * Client Secure Portal

 * Lab Testing Services Overview
 * Analytical Testing Services
 * Batch Release & Stability Lot Testing
   
 * Method Development & Validation
 * Package & Device Testing
 * Solid State Chemistry

 * Consultative Services Overview
 * Intellectual Property Litigation Support
 * Intellectual Property Services
   
 * Regulatory Support
 * Quality Assurance
 * Sterile University

icons/utility/left caret About Us
icons/utility/left caret Biologics
icons/utility/left caret Research & Development
icons/utility/left caret Manufacturing
icons/utility/left caret Lab Testing
icons/utility/left caret Discovery
icons/utility/left caret Development
icons/utility/left caret Manufacturing
icons/utility/left caret Assays & Bioanalytics
icons/utility/left caret Resources
icons/utility/left caret Discovery
icons/utility/left caret Development
icons/utility/left caret Lab Testing Services
icons/utility/left caret Consultative Services
icons/utility/left caret Consultative Services


Icon - Magnifying Glass
Close Button
EVENT


UNLOCKING HIGH-THROUGHPUT BIOLOGY IN DRUG DISCOVERY

Join Curia and Carterra for our 2024 Symposium Series. Attend to discuss the
latest technologies in antibody discovery, AI/ML, and small molecule
applications. There is no cost to attend, but seating is limited. Reserve your
seat today!

May 31, 2024
Register Now

CURIA INSIGHTS


IN VITRO CHARACTERIZATION OF A DUAL ANTAGONISTIC ANTI-LILRB2/LILRB4 MONOCLONAL
ANTIBODY

Available now! Our recent AACR Annual Meeting poster presentation co-authored
with Tonix Pharmaceuticals titled “In Vitro Characterization of a Dual
Antagonistic Anti-LILRB2/LILRB4 Monoclonal Antibody” where presenters discussed
anti-LILRB2/LILRB4 monoclonal antibody.


Download

CURIA INSIGHTS


THE SHIFT TOWARD WESTERN PHARMACEUTICAL MANUFACTURING: CONSIDERATIONS IN
ATTAINING THE RIGHT GLOBAL MIX

In this white paper we discuss effective strategies to secure and de-risk
pharmaceutical supply chains and reveal how Curia assures the continual
production of urgently needed drugs.


Learn More

EVENT


BIO INTERNATIONAL CONVENTION

Curia is a trusted partner to support you at any stage of your product
development. We specialize in complex chemistry and deliver consistent quality
that seamlessly scales to the next phase. Schedule a meeting or come by booth
4607.

June 3 - 6, 2024
Schedule a Meeting

CURIA SERVICES


STERILE FILL FINISH MANUFACTURING

From formulation / process development to clinical phase production and
commercial sterile manufacturing, Curia offers the capacity, flexibility and
scalability to bring your product to market.


Learn More

 1. 
 2. 
 3. 
 4. 
 5. 

The latest

Curia and Carterra Partner on Biologics Symposium to Further Biotechnology
Research in the Pacific Northwest F8E87338-1FC1-4EEF-B1C3-4A13B1DAB056



END-TO-END CAPABILITIES

The journey to medical breakthrough may be linear, but it’s never simple. From
discovery through manufacturing, launch through commercialization, we leverage
deep scientific expertise and state-of-the-art technology to ensure every stage
of this intricate process advances as quickly and accurately as possible.

Group
Group
Continuum

Capability spotlight


EXPLORE OUR LATEST INNOVATIONS AND ADVANCED CAPABILITIES



ANTIBODY DISCOVERY CAPABILITIES

RARE / ORPHAN

HIGH POTENCY


SOME BONDS CAN’T BE BROKEN



Science is objective. Measured. Rational. That doesn’t mean it’s heartless. From
discovery and development through manufacturing and beyond, Curia balances the
science of impact with the art of possibility, working together with our
partners to not only deliver therapies, but change lives for the better.




DISCOVER THE LATEST FROM OUR EXPERTS

More insights icons/utility/caret

040E93C7-D189-4233-A102-58C0580BE529 publications patents

Poster: In Vitro Characterization of a Dual Antagonistic Anti-LILRB2/LILRB4
Monoclonal Antibody

icons/content-types/article article

Trends and Challenges in the Pharmaceutical Industry

icons/content-types/white paper white paper

Continuous Flow – An Emerging Alternative


READY TO MOVE FROM IDEA TO IMPACT?

Get started
 * Careers
 * Suppliers
 * Contact us
   

 * About us
 * Biologics
 * Research & Development
 * Manufacturing
 * Lab Testing
 * Insights

Curia and Carterra Partner on Biologics Symposium to Further Biotechnology
Research in the Pacific Northwest

May 9, 2024

Curia Appoints Steve Lavezoli as Vice President, Biologics

February 23, 2024

More News icons/utility/right caret
Curia - Logo - Molecules
©2024 Curia Global, Inc. All rights reserved.

Do not sell my personal information

|

Privacy Policy|Terms of Use|Terms & Conditions

Icon LinkedIn Icon Twitter Icon Facebook
The trade/service marks used herein are the property of Curia or their
respective owners. Use of the ® symbol indicates that the mark has been
registered in at least the United States. Use of the TM or SM symbol indicates
that the mark is in use in at least the United States.

NOTICE: Please Be Aware of False Employment Opportunities
Any job applicant who applies to Curia must submit their application through
Curia’s career page at https://careers.curiaglobal.com. Applicants will only
receive communication, including offer letters, from a curiaglobal.com email
address. Please be aware that recent scams used email addresses that are similar
to Curia addresses or use other public domain addresses such as gmail.com,
yahoo.com and aol.com. Please confirm the sender’s email address prior to
sharing your information. Thank you.

CLOSE